Baobab Healthcare

Baobab Healthcare is a South Korean biotechnology company founded by CEO Hojun Jeon in October 2019, specializing in human tissue regeneration through 3D bioprinting technology. The company is composed of a core team of experts in the 3D bioprinting field and produces its own specialized bioprinters and bio-inks. Leveraging its expertise in printing soft tissues, the company has expanded into the food technology sector to address climate change and food security issues.

The company's main product is "Clean Fish," a cell-cultured seafood alternative that replicates the taste and texture of conventional seafood. This product is created by mixing seafood-derived cells with an edible bio-ink and printing it to mimic the structure of fish tissue. The process aims to provide a sustainable food source that is free from marine pollutants like microplastics, heavy metals, and radiation. Baobab Healthcare has developed its own 3D bioprinter, the 'Root_1', to facilitate this process. The firm also internalizes the production of key materials like atelo-collagen, a crucial component for its bio-inks.

In addition to food tech, the company remains active in the medical field, developing products such as artificial blood vessels, custom orthotics, and artificial skin. The company has received recognition for its innovations, winning the grand prize in the commercialization category at the 2022 Marine and Fisheries Startup Contest hosted by the Ministry of Oceans and Fisheries. In March 2023, it entered into an MOU with Kcell Biosciences to develop a dedicated culture medium for its cultivated seafood products.

Keywords: 3D bioprinting, cell-cultured seafood, cultivated fish, clean fish, food technology, alternative protein, sustainable food, tissue engineering, bio-ink, cellular agriculture, artificial tissue, Hojun Jeon, marine pollution solution, food security, regenerative medicine, biotechnology, alternative seafood, cultured protein, food tech startup